Digest Network Come funziona
Network
/
Società
C₂
Non verificato

C₂N Diagnostics, LLC

Di cosa scriviamo

BiotecnologiaIndustriaMedicina - VarieSaluteScienza

16 comunicati stampa

Guarda tutti i comunicati
13/11/2025
Psichiatria
Salute
Scienza
Eventi
C2N Diagnostics and WashU Medicine Teams Receive Prestigious Award from Human Proteome Organization
Fonte
C₂N Diagnostics, LLC
Emittente
Business Wire
1.00
0
25/09/2025
Industria
Sanità
Terza età
Medicina - Varie
Scienza
Biotecnologia
Vetrine/Shopping
Salute
New Research Reinforces C2N’s PrecivityAD2™ Blood Test as a Highly Accurate Tool to Detect Brain Amyloid Pathology in Symptomatic Patients
Fonte
C₂N Diagnostics, LLC
Emittente
Business Wire
1.00
0
03/09/2025
Dynamic Growth Leads C2N Diagnostics to Expand St. Louis Headquarters to Meet Global Need for Answers to Alzheimer’s Disease
Fonte
C₂N Diagnostics, LLC
Emittente
Business Wire
1.00
0
25/08/2025
Sanità
Vetrine/Shopping
Medicina - Varie
Biotecnologia
Terza età
Salute
Industria
C2N Diagnostics Expands the PrecivityAD2™ Alzheimer’s Disease Blood Test Intended Use to Patients 50 Years and Older
Fonte
C₂N Diagnostics, LLC
Emittente
Business Wire
1.00
0
07/08/2025
Scienza
Psichiatria
Medicina - Varie
Biotecnologia
Sanità
Farmaceutica
Salute
Mercato del lavoro
Industria
C2N Announces Major Global Expansion, Adds Six New International Partners
Fonte
C₂N Diagnostics, LLC
Emittente
Business Wire
1.00
0
15/07/2025
Psichiatria
Scienza
Medicina - Varie
Biotecnologia
Salute
Farmaceutica
Sanità
Industria
C2N Diagnostics Expands Portfolio of Blood Tests for Clinical Researchers Studying Alzheimer’s Disease and Related Dementias
Fonte
C₂N Diagnostics, LLC
Emittente
Business Wire
1.00
0
13/03/2025
Mercato del lavoro
Attrezzature medico-sanitarie
Salute
Sanità
Biotecnologia
Samsung Invests in C2N Diagnostics
Fonte
C₂N Diagnostics, LLC
Emittente
Business Wire
1.00
0
24/02/2025
Biotecnologia
Attrezzature medico-sanitarie
Sanità
Salute
Medicina - Varie
Industria
C2N Diagnostics’ PrecivityAD2™ Blood Test Receives MHRA Medical Device Certification in the United Kingdom
Fonte
C₂N Diagnostics, LLC
Emittente
Business Wire
1.00
0
31/01/2025
Scienza
Biotecnologia
Sanità
Salute
Psichiatria
Medicina - Varie
Analisi di mercato
Industria
Study Highlights How C2N’s PrecivityAD2™ Blood Biomarker Test Use Improves Clinical Decision-Making in the Evaluation for Alzheimer’s Disease
Fonte
C₂N Diagnostics, LLC
Emittente
Business Wire
1.00
0
28/01/2025
Scienza
Biotecnologia
Attrezzature medico-sanitarie
Salute
Psichiatria
Industria
First Canadian Clinic to Offer C2N’s PrecivityAD2™ Blood Test to Help Healthcare Providers Diagnose Alzheimer’s Disease, Joining Global Community in Embracing Breakthrough Technology
Fonte
C₂N Diagnostics, LLC
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0